Living in the 'post-antibiotic era': Could the use of probiotics be an effective strategy?

Clinical Microbiology and Infection

Volumn 3, Issue 1, 1997, Pages 2-4

  Hamilton Miller, J M T ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ASPERGILLUS; LONGEVITY; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; SACCHAROMYCES BOULARDII;

ASPERGILLUS; SACCHAROMYCES BOULARDII;

EID: 0030891459     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1997.tb00242.x     Document Type: Article

References (28)

1. Neu HC The crisis in antibiotic resistance Science 257 1992 1064 1073
2. Brickner SJ Hutchison DK Barbachyn MR Manninen PR Ulanowicz DA Garmon SA Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multi-drug resistant Gram-positive bacterial infections J Med Chem 39 1996 673 679
3. Nakashio S Iwasawa H Dun FY Kanemitsu K Shimida J Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity Drugs Expd Clin Res 21 1995 7 16
4. Stachelhaus T Schneider A Marahiel MA Engineered biosynthesis of peptide antibiotics Biochem Pharmacol 52 1996 177 186
5. Hancock REW Falla TJ Antimicrobial peptides: broad-spectrum antibiotics from nature Clin Microbiol Inf 1 1996 226 229
6. Canepari P Boaretti M Lipoteichoic acid as a target for antimicrobial action Microb Drug Res 2 1996 85 89
7. Kopp U Roos M Wecke J Labischinksi H Staphylococcal peptidoglycan interpeptide bridge biosynthesis: a novel antistaphylococcal target? Microb Drug Res 2 1996 29 41
8. Zopf D Roth S Oligosaccharide anti-infective agents Lancet 347 1996 1017 1021
9. Chin J Resistance is useless New Scient 152 Oct 12 1996 32 35
10. Grange JM Stanford JL Therapeutic vaccines J Med Microbiol 45 1996 81 83
11. Bibel DJ Elie Metchnikoff's bacillus of long life ASM News 54 1988 661 665
12. Vollaard EJ Claesner HAL Colonization resistance Antimicrob Agents Chemother 38 1994 409 414
13. McFarland LV Surawicz CM Greenberg RN Elmer GW Moyer KA Melcher SA Prevention of β-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo Amer J Gastroenterol 90 1995 439 448
14. Wallace RJ Newbold CM Microbial feed additives for ruminants Fuller R Probiotics: Prospects of Use in Opportunistic Infections 1995 Institute for Microbiology and Biochemistry, Herborn Dill 101 125
15. Lee Y-K Salminen S The coming of age of probiotics Trends Fd Sci Technol 6 1995 241 245
16. Saxelin M Chuang N-H Chassy B Rautelin H Makela PH Salminen S Lactobacilli and bacteremia in Southern Finland, 1989–1992 Clin Inf Dis 22 1996 564 566
17. Jett BD Huycke MM Gilmore MS Virulence of enterococci Clin Microbiol Rev 7 1994 462 478
18. Reid G Bruce AW McGroarty JA Cheng K-J Costerton LW Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 3 1990 335 344
19. Fuller R Probiotics in human medicine Gut 32 1991 439 442
20. Goldin BR Gorbach SL Probiotics for humans Fuller R. Probiotics, The Scientific Basis 1992 Chapman & Hall London 355 376
21. McGroarty JA Probiotic use of lactobacilli in the human female urogenital tract FEMS Immunol Med Microbiol 6 1993 251 264
22. Bergogne-Berezin E Impact ecologique de l'antibiotherapie Presse Med 24 1995 145 156
23. Tannock GW Role of probiotics Gibson GR Human Colonic Bacteria: Role in Nutrition 1995 CRC Press Boca Raton 257 271
24. Rusch VC Zimmerman K Microbial therapy with Enterococcus faecalis and Escherichia coli : experimental and clinical data Fuller R Probiotics: Prospects of Use in Opportunistic Infections 1995 Institute of Microbiology and Biochemistry Herborn-Dill 158 172
25. Araneo BA Cebra JJ Beuth J Fuller R Heidt PJ Midvedt T Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; an overview of current literature Z Bakt 283 1996 431 465
26. Hamilton-Miller JMT Probiotics – panacea or nostrum? BNF Nutrit Bull 21 1996 199 208
27. Alpert JS The relativity of alternative medicine Arch Int Med 155 1995 2385
28. Barnett AA Nutraceuticals seek credibility in USA Lancet 347 1996 1397